Abstract 22q11. 2 deletion syndrome (22q11. 2DS) is the most common chromosomal
microdeletion disorder, estimated to result mainly from de novo non-homologous meiotic …

This review aimed to update the clinical practice guidelines for managing children and
adolescents with 22q11. 2 deletion syndrome (22q11. 2DS). The 22q11. 2 Society, the …

The DiGeorge/velocardiofacial syndrome (DGS/VCFS) is a relatively common human
disorder, usually associated with deletions of chromosome 22q11. The genetic basis for the …

Objectives. Although several studies describe the 22q11. 2 deletion, population-based data
are scant. Such data are needed to evaluate properly the impact, distribution, and clinical …

Summary Chromosome 22q11. 2 deletion syndrome is the most common microdeletion
syndrome in humans. The effects are protean and highly variable, making a unified …

Abstract The 22q11. 2 deletion syndrome has an estimated prevalence of 1 in 4–6,000
livebirths. The phenotype varies widely; the most common features include: facial …

Chromosome 22q11. 2 deletion syndrome (22q11. 2DS), a neurogenetic condition, is the
most common microdeletion syndrome affecting 1 in 2,000–4,000 live births and involving …

This review provides an overview of the involvement of the corpus callosum (CC) in a variety
of developmental disorders that are currently defined exclusively by genetics …

OBJECTIVE: To examine psychopathology and influence of intelligence level on psychiatric
symptoms in children with the 22q11. 2 deletion syndrome (22q11DS). METHOD: Sixty …

Abstract Purpose The chromosome 22q11. 2 deletion has been identified in the majority of
patients with DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face …